Join us on our Medical Mystery Tour!

As a medical professional, you may need to diagnose a wide variety of disorders, initiate treatment regimens and decide when specialist referral or emergency management and hospitalization are necessary – particularly in the diagnosis and treatment of rare or unusual clinical diseases or syndromes. This 4-part webinar series will cover current clinical information on the diagnosis and treatment of rare medical conditions such as Acute Lyme Disease, Spontaneous Bowel Rupture, Rare Fungal Infections including Blastomycosis and Mast Cell Activation Syndrome.

These webinars are free for Society members, but registration is required. Non-members are welcome to attend as well. Sessions will be available on demand after each live session occurs.

Participants view the presentation and listen to the synchronized audio of the live lecture. After completing the activity, participants must complete an evaluation in order to receive AMA PRA Category 1 Credit™.

Education Credit

Accreditation Statement
The Wisconsin Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Wisconsin Medical Society designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

If you have questions, contact education@wismed.org.

Webinar Sessions

Click here to register for this webinar series!

Lyme Disease - Background and Acute Management
Samuel Shor, MD, FACP
June 7, 2021, 12:15-12:45 p.m. 

Upon completion of this activity, learners will be able to demonstrate an understanding of rare or unusual clinical disease states or syndromes, and improvement in response to the management of tick bite prophylaxis and acute Lyme disease leading to improved diagnosis and treatment for better patient care.

Spontaneous Bowel Rupture: Connective Tissue Considerations
Elizabeth Petty, MD
June 14, 2021, 12:15-12:45 p.m. 

Illustrative cases of spontaneous bowel rupture will be discussed with a lens toward understanding underlying connective tissue contributions. The expected outcome will be an increased knowledge of the differential diagnosis of heritable causes of spontaneous bowel rupture, the ability to describe characteristic clinical features of connective tissue disorders associated with spontaneous bowel rupture, the ability to demonstrate the importance of family history in assessing connective tissue contributions to bowel rupture and the ability to outline management strategies of patients with heritable connective tissue disorders associated with spontaneous bowel rupture. 

Rare Fungal Infections Including Blastomycosis
Greg Gauthier, MD, MS
June 21, 2021, 12:15-12:45 p.m. 

This talk with focus on the 3 major dimorphic fungal infections in North America including clinical recognition, diagnosis and treatment. The expected outcome will be an increased knowledge of rare or unusual clinical disease states or syndromes. Awareness of the major dimorphic fungi in North America including geographic distribution, basic concepts in fungal pathogenesis, increased knowledge about when to think about an invasive fungal infection and an understanding of how to use the different diagnostic tests. The topic of which antifungal drugs to use against the dimorphic fungi which may lead to improved diagnosis and treatment for better patient care will be discussed.

Anaphylaxis without an allergy: An introduction to mast cell disorders
Joshua Steinberg, MD
June 28, 2021, 12:15-12:45 p.m. 

This webinar will review cases and typical presentation, evaluation and management of mast cell disorders. The expected outcome will be an increased knowledge of rare or unusual clinical disease states or syndromes. Understanding the physiology and pathophysiology of anaphylaxis, consideration of which features would prompt evaluation for mast cell disorder and a review of the crisis of inappropriate diagnosis and pseudoscience with mast cell disorders may lead to improved diagnosis and treatment for better patient care.